Human immunodeficiency virus (HIV) works by entering specific immune cells and replicating inside them. People with HIV are treated with antiretroviral therapy (ART), which prevents viral replication, but some individuals ...
Nov 14, 2023
0
0
Lenacapavir, an injection, has been approved by the FDA for multi-drug resistant HIV.
Sep 1, 2023
0
23
Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most ...
Jul 21, 2023
0
11
If taken within 72 hours of condomless sex, the common antibiotic doxycycline drastically reduces the risk of gonorrhea, syphilis and chlamydia among transwomen and gay, bisexual and other men who have sex with men, a recent ...
Jul 14, 2023
0
22
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens.
Dec 30, 2022
0
57
University of Oxford researchers assessed evidence from 34 studies, involving more than 57,000 pregnant women with HIV, and found that protease inhibitor-based antiretroviral therapies significantly increased the risk of ...
Apr 12, 2022
0
30
In the late 1980s, when HIV treatments were first introduced, patients would often develop resistance to those treatments within six months. The introduction of triple-drug treatment regimens in the 1990s was intended to ...
Nov 26, 2021
0
5
The COVID-19 pandemic had a "devastating" impact on the fight against HIV, tuberculosis and malaria in 2020, according to a report released by the Global Fund on Wednesday.
Sep 8, 2021
0
16
Researchers have designed a device that delivers two medications that help stop HIV transmission.
Jun 17, 2021
0
8
Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day. The study finds that this so-called 'wonder drug' may be less ...
Dec 1, 2020
0
28
